Intravenous anaesthesia greatly reduces CO₂ emissions: comparable to annual emissions of Denmark

“Three different anaesthetic gases are used to anesthetise patients for surgery: sevoflurane, isoflurane and desflurane,” explains Sperna Weiland. “These are so-called F-gases, strong greenhouse gases that are used in cooling systems, for example, and that together cause about 5 percent of global warming. The anaesthetic gases retain much more heat than CO₂: sevoflurane is 500 times stronger than CO₂, desflurane even 7,000 times.” The alternative is much more environmentally friendly: intravenous anaesthesia, anaesthesia via an infusion. “By switching from desflurane to intravenous anaesthesia, you save 98 percent of CO₂ emissions. Switching from sevoflurane – the least harmful anaesthetic gas – to intravenous saves 80 percent.” 

Less nausea and less confusion 

Desflurane and isoflurane have now virtually disappeared from Dutch clinical practice and sevoflurane is also used less and less. This is the result of the efforts of Sperna Weiland and his team. “Our research showed that two conditions are essential for our colleagues: patient safety and professional autonomy. There should be no doubt about the first. PhD candidate Jasper Kampman therefore conducted a meta-analysis of the studies that compared the effects of intravenous anaesthesia with those of anaesthesia with anaesthetic gases. This showed that there is no difference in terms of patient safety and that intravenous anaesthesia does not lead to more complications. On the contrary, after anaesthesia via an IV, people are less nauseous and less confused. This ensures a better recovery. Because patients spend less time in the recovery room and need less medication for nausea, it’s also cheaper.” 

Intravenous first choice

Strengthened by these scientific insights, and now with a subsidy for further national implementation, Sperna Weiland and Kampman went looking for reinforcement to spread the message more widely. “Together with specialists in the field of communication and behavioural change, we set up a campaign for anaesthesiologists, under the slogan ‘Intravenous, if possible, gas if necessary’.” The guidelines of the Dutch Anaesthesiology Society have also been adjusted: “Every professional group must now have a protocol stating that intravenous anaesthesia is the first choice. Anaesthesiologists can add a list of indications for vapor anaesthesia to this protocol at their own discretion, because for some patients this remains necessary.” 

Political urgency 

The figures and arguments that Sperna Weiland and colleagues listed did not go unnoticed by policymakers. For example, ‘Anesthetising differently’ became one of the measures in the 54 Point Plan, the guideline from environmental organization Urgenda to the Dutch government to achieve a 25% CO₂ reduction in 2025. A recent milestone is the new European F-gas legislation that will come into effect on 1 January 2026. “In this, the use of desflurane is subject to so many rules and administration that it is virtually banned,” says Sperna Weiland happily. “The fact that this is possible for a medicine that works well in itself, based solely on environmental arguments, is unique.” 

Impact in China 

The anaesthesiologist has now travelled to the Chinese National Health Committee in Beijing twice with a delegation from the Dutch Ministry of Health, Welfare and Sport. “China is already struggling with the consequences of global warming and enormous steps are being taken in the energy transition. Our project can therefore be well received there. I am struck by how open our colleagues there are to it. With great potential impact: in the Netherlands there are approximately 2,500 anaesthesiologists, in China there are 112,000 in 35,000 hospitals. Only on that scale can we really make a difference. Because 97 percent of anaesthesiologists in China are not yet aware of the climate impact, we will first have all available scientific information translated into Chinese.”